Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine.
Georgian Med News. 2022 Jan(322):131-139.
The purpose of the study is to examine in depth and analyze renal, hepatic and immune function indices in patients who suffered from neuromuscular disorders: аmyotrophic lateral sclerosis and Duchenne muscular dystrophy (one-year prospective follow-up). We analyzed the follow up clinical and laboratory data of 55 patients, aged 56±10, with amyotrophic lateral sclerosis and 53 patients, aged 18±5, with Duchenne muscular dystrophy at presentation and a year after the treatment. The patients underwent a standardized examination, involving studying the medical case history, general clinical data, the detailed neurological status examination, laboratory and instrumental examinations. Through the laboratory examination we determined the general blood test indicators, total serum protein levels, total cholesterol, the ALAT, ASAT, CPK levels, creatinine and serum urea levels, glomerular filtration rate (GFR), the lactic dehydrogenase level, the alkaline phosphatase level, the immunogram indices (dynamic data (B-lymphocytes (CD19/CD45),%; T-lymphocytes (CD3/CD 45),%; T-helpers (CD3/CD45/CD4),%; T-suppressors (CD3/CD45/ CD8),%; CD4:CD8 ratio; natural killer cells ratio. The instrumental examination included the ultrasound of the abdominal organs, muscles, as well as echo-cardiography, electroneuromyography. Having analyzed the renal, hepatic and immunological indices in patients with such neuromuscular disorders as аmyotrophic lateral sclerosis and Duchenne muscular dystrophy, we found that both the patients with аmyotrophic lateral sclerosis and those with Duchenne muscular dystrophy suffered from renal dysfunction. Thus, most patients with аmyotrophic lateral sclerosis (69%) were observed to have the below normal serum creatinine level and 5,5% of the patients had the above normal serum creatinine level. A similar situation was observed in patients with Duchenne muscular dystrophy: 58.5% of the patients were detected to have the below normal serum creatinine level and 3.8% of the patients had the above normal serum creatinine level. At the same time, 40% of 25 patients with Duchenne muscular dystrophy, who we followed up, had low serum creatinine at presentation, while a year later, the%age of the patients increased to 44%. The serum urea level was within normal limits in most patients (89,1%) with аmyotrophic lateral sclerosis and in all the patients with Duchenne muscular dystrophy. The glomerular filtration rate was observed to be within the reference value in most patients with аmyotrophic lateral sclerosis and in all the patients with Duchenne muscular dystrophy (at presentation and a year after the treatment), however, it was observed a mild renal filtration dysfunction in 21,8% of patients with аmyotrophic lateral sclerosis; it was found a moderate renal filtration dysfunction in 5,5% of patients with аmyotrophic lateral sclerosis. At that we detected a weak positive correlation between the glomerular filtration rate and the lifespan of patients with аmyotrophic lateral sclerosis (r=0.28, p<0.01). Concurrently, we found no correlation between the serum creatinine and myoparesis severity in patients with аmyotrophic lateral sclerosis that somewhat contradicts Inês Martins' findings obtained in 2020. The serum aspartate aminotransferase level was found to be above normal in 40% of patients with amyotrophic lateral sclerosis (at the same time the alanine aminotransferase level was observed to be above normal only in 18% of the patients). The lactic dehydrogenase level was below normal in most patients. We found the significant changes when evaluating the immune status in patients with amyotrophic lateral sclerosis: almost all the patients (94.5%) had decreased levels of B-lymphocytes; 41.8% of patients had a reduced level of a subpopulation of T-lymphocytes - T-suppressors. The conducted comprehensive longitudinal study has shown the presence of significant predictive renal function impairments in patients with amyotrophic lateral sclerosis and Duchenne muscular dystrophy. The patients with amyotrophic lateral sclerosis were detected to have significantly deviated B-cell and T-cell components of the immune status and enzyme systems, including lactate dehydrogenase and aspartate aminotransferase levels; their nature and prognostic value need further investigation.
研究目的在于深入探讨和分析神经肌肉疾病患者的肾脏、肝脏和免疫功能指标:肌萎缩侧索硬化症和杜氏肌营养不良症(为期一年的前瞻性随访)。我们分析了 55 名肌萎缩侧索硬化症患者和 53 名杜氏肌营养不良症患者的临床和实验室数据,这些患者在就诊时和治疗一年后分别为 56±10 岁和 18±5 岁。患者接受了标准化检查,包括研究病历、一般临床数据、详细的神经状态检查、实验室和仪器检查。通过实验室检查,我们确定了一般血液检查指标、总血清蛋白水平、总胆固醇、丙氨酸氨基转移酶、天门冬氨酸氨基转移酶、肌酸磷酸激酶水平、肌酐和血清尿素水平、肾小球滤过率、乳酸脱氢酶水平、碱性磷酸酶水平、免疫图谱指数(动态数据(B 淋巴细胞(CD19/CD45),%;T 淋巴细胞(CD3/CD45),%;T 辅助细胞(CD3/CD45/CD4),%;T 抑制细胞(CD3/CD45/CD8),%;CD4:CD8 比值;自然杀伤细胞比值。仪器检查包括腹部器官、肌肉的超声检查以及超声心动图、肌电图。对肌萎缩侧索硬化症和杜氏肌营养不良症等神经肌肉疾病患者的肾脏、肝脏和免疫指标进行分析后,我们发现肌萎缩侧索硬化症患者和杜氏肌营养不良症患者均存在肾功能障碍。因此,大多数肌萎缩侧索硬化症患者(69%)的血清肌酐水平低于正常值,5.5%的患者的血清肌酐水平高于正常值。在杜氏肌营养不良症患者中也观察到类似的情况:58.5%的患者的血清肌酐水平低于正常值,3.8%的患者的血清肌酐水平高于正常值。同时,我们随访的 25 名杜氏肌营养不良症患者中有 40%在就诊时的血清肌酐水平较低,而一年后,患者的%数增加到 44%。大多数肌萎缩侧索硬化症患者(89.1%)和所有杜氏肌营养不良症患者的血清尿素水平均在正常范围内。在就诊时和治疗一年后,大多数肌萎缩侧索硬化症患者的肾小球滤过率均在参考值范围内,所有杜氏肌营养不良症患者的肾小球滤过率也在参考值范围内,但在 21.8%的肌萎缩侧索硬化症患者中观察到轻度的肾功能滤过功能障碍,在 5.5%的肌萎缩侧索硬化症患者中观察到中度的肾功能滤过功能障碍。我们发现肌萎缩侧索硬化症患者的肾小球滤过率与患者的寿命之间存在微弱的正相关关系(r=0.28,p<0.01)。同时,我们在肌萎缩侧索硬化症患者中没有发现血清肌酐与肌病严重程度之间的相关性,这与 Inês Martins 在 2020 年的研究结果有些矛盾。在肌萎缩侧索硬化症患者中,有 40%的患者血清天门冬氨酸氨基转移酶水平高于正常值(同时,只有 18%的患者丙氨酸氨基转移酶水平高于正常值)。乳酸脱氢酶水平在大多数患者中低于正常值。在评估肌萎缩侧索硬化症患者的免疫状态时,我们发现了显著的变化:几乎所有患者(94.5%)的 B 淋巴细胞水平降低;41.8%的患者 T 淋巴细胞亚群——T 抑制细胞的水平降低。进行的全面纵向研究表明,肌萎缩侧索硬化症和杜氏肌营养不良症患者的肾功能存在显著的预测性损害。肌萎缩侧索硬化症患者的 B 细胞和 T 细胞免疫状态和酶系统成分显著偏离,包括乳酸脱氢酶和天门冬氨酸氨基转移酶水平;它们的性质和预后价值需要进一步研究。